These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 28061475)

  • 1. Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets.
    Lin J; Chuang CC; Zuo L
    Oncotarget; 2017 Mar; 8(10):17328-17346. PubMed ID: 28061475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA biomarkers predicting risk, initiation and progression of colorectal cancer.
    Lee K; Ferguson LR
    World J Gastroenterol; 2016 Sep; 22(33):7389-401. PubMed ID: 27672263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of microRNAs in colorectal liver metastasis: Important participants and potential clinical significances.
    Wang D; Liu J; Huo T; Tian Y; Zhao L
    Tumour Biol; 2017 Jun; 39(6):1010428317709640. PubMed ID: 28651498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential biomarkers associated with oxidative stress for risk assessment of colorectal cancer.
    Mandal P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):557-565. PubMed ID: 28229171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of microRNAs in colorectal cancer.
    Mohammadi A; Mansoori B; Baradaran B
    Biomed Pharmacother; 2016 Dec; 84():705-713. PubMed ID: 27701052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
    Hibner G; Kimsa-Furdzik M; Francuz T
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer characterization and therapeutic target prediction based on microRNA expression profile.
    Xu P; Zhu Y; Sun B; Xiao Z
    Sci Rep; 2016 Feb; 6():20616. PubMed ID: 26852921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico identification of microRNAs as candidate colorectal cancer biomarkers.
    Fadaka AO; Klein A; Pretorius A
    Tumour Biol; 2019 Nov; 41(11):1010428319883721. PubMed ID: 31718480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox regulation of microRNAs in cancer.
    Lan J; Huang Z; Han J; Shao J; Huang C
    Cancer Lett; 2018 Apr; 418():250-259. PubMed ID: 29330105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.
    Wan TM; Iyer DN; Ng L
    Histol Histopathol; 2020 Mar; 35(3):225-237. PubMed ID: 31617575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress causes epigenetic alteration of CDX1 expression in colorectal cancer cells.
    Zhang R; Kang KA; Kim KC; Na SY; Chang WY; Kim GY; Kim HS; Hyun JW
    Gene; 2013 Jul; 524(2):214-9. PubMed ID: 23618814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of microRNA-31 expression in early colorectal cancer.
    Tateishi Y; Okudela K; Mitsui H; Umeda S; Suzuki T; Kojima Y; Watanabe K; Kawano N; Endo I; Ohashi K
    Pathol Int; 2015 Oct; 65(10):513-8. PubMed ID: 26173758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNAs in the Malignant Transformation Process.
    Sarver AE; Li L; Kartha RV; Subramanian S
    Adv Exp Med Biol; 2015; 889():1-21. PubMed ID: 26658993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of circulating microRNAs-211 and 25 as diagnostic biomarkers of colorectal cancer.
    Radwan E; Shaltout AS; Mansor SG; Shafik EA; Abbas WA; Shehata MR; Ali M
    Mol Biol Rep; 2021 May; 48(5):4601-4610. PubMed ID: 34132944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Methylation in Colorectal Cancer.
    Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
    Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in colorectal cancer as markers and targets: Recent advances.
    Ye JJ; Cao J
    World J Gastroenterol; 2014 Apr; 20(15):4288-99. PubMed ID: 24764666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive oxygen species in colorectal cancer: The therapeutic impact and its potential roles in tumor progression via perturbation of cellular and physiological dysregulated pathways.
    Moradi-Marjaneh R; Hassanian SM; Mehramiz M; Rezayi M; Ferns GA; Khazaei M; Avan A
    J Cell Physiol; 2019 Jul; 234(7):10072-10079. PubMed ID: 30515827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
    Clancy C; Joyce MR; Kerin MJ
    Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.